A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC. (Q38852985)
Jump to navigation
Jump to search
scientific article published on July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC. |
scientific article published on July 2015 |
Statements
1 reference
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC. (English)
1 reference
Helai P Mohammad
1 reference
Kimberly N Smitheman
1 reference
Chandrashekhar D Kamat
1 reference
David Soong
1 reference
Kelly E Federowicz
1 reference
Glenn S Van Aller
1 reference
Jess L Schneck
1 reference
Jeffrey D Carson
1 reference
Yan Liu
1 reference
Michael Butticello
1 reference
William G Bonnette
1 reference
Shelby A Gorman
1 reference
Yan Degenhardt
1 reference
Yuchen Bai
1 reference
Michael T McCabe
1 reference
Melissa B Pappalardi
1 reference
Jiri Kasparec
1 reference
Xinrong Tian
1 reference
Kenneth C McNulty
1 reference
Meagan Rouse
1 reference
Patrick McDevitt
1 reference
Thau Ho
1 reference
Michelle Crouthamel
1 reference
Timothy K Hart
1 reference
Nestor O Concha
1 reference
Charles F McHugh
1 reference
William H Miller
1 reference
Dashyant Dhanak
1 reference
Peter J Tummino
1 reference
Christopher L Carpenter
1 reference
Neil W Johnson
1 reference
Christine L Hann
1 reference
Ryan G Kruger
1 reference
1 July 2015
1 reference
1 reference
28
1 reference
1
1 reference
57-69
1 reference
Identifiers
1 reference
1 reference